FDA approves higher-dose Wegovy to help people lose more weight

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Food and Drug Administration (FDA) approved a 7.2-milligram dose of Novo Nordisk’s semaglutide, the active ingredient in Wegovy. Until now, the highest approved dose was 2.4 milligrams, taken as a weekly shot.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup